Exact Sciences (EXAS) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
20 Feb, 2026Opening remarks and agenda
The meeting was called to order by the Chairman, with board members and the Inspector of Election present.
The agenda and rules of conduct were made available online, and the meeting would follow the set agenda.
Shareholder proposals
Three proposals were presented: approval of a merger agreement, advisory approval of executive compensation related to the merger, and approval of adjournment if more proxy votes were needed.
Q&A with stakeholders
Stockholders could submit questions online, limited to one per person, with follow-up promised for unanswered questions.
Updates were provided on regulatory approvals for the merger, expected to complete before the end of Q2 2026.
Ongoing merger-related litigation was referenced, with details available in recent SEC filings.
Latest events from Exact Sciences
- International expansion accelerates with new products, offices, and integration with Abbott.EXAS
Proxy Filing17 Feb 2026 - Record revenue, improved cash flow, and major merger plans mark a transformative year.EXAS
Q4 202513 Feb 2026 - Merger with Abbott at $105 per share prompts supplemental disclosures and litigation response.EXAS
Proxy Filing10 Feb 2026 - Multi-cancer early detection is poised to transform cancer care, reducing mortality and costs.EXAS
7th Annual Healthcare Symposium3 Feb 2026 - All proposals passed, with director elections, auditor ratification, and no shareholder questions.EXAS
AGM 20243 Feb 2026 - Q2 revenue up 12% to $699M; record test volumes and raised EBITDA guidance.EXAS
Q2 20242 Feb 2026 - Cologuard Plus, automation, and global expansion fuel strong growth and margin gains.EXAS
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Cologuard Plus and a robust pipeline position the company for sustained growth and market leadership.EXAS
Jefferies Global Healthcare Conference1 Feb 2026 - Growth driven by innovative cancer diagnostics, strong provider network, and agile leadership.EXAS
The 44th Annual William Blair Growth Stock Conference31 Jan 2026